New Head of ISC And Outlook For ISC West 2022

By John Honovich, Published Jan 18, 2022, 09:11am EST (Info+)

With ISC West 2022 just 2 months away, the previous head of the show, Will Wise is out, and a replacement has been made, Jordan Tuchband.

IPVM Image

IPVM spoke with Tuchband to better understand the state of the show after a chaotic past 2 years of the show being rescheduled 4 times and radically lower attendance in 2021.

Wise ***

IPVM Image

**** ******* *** *** ****** ***** ****, left ** *** *** ** ****. Wise **** ** ** *** ********** ***********, * ***** ******* ***** ******* that *********** ** "******* *** ***********". Wise *** *** ***** ** ******** requests *** ******** ***, ********* ** people ***** ** *** *********, **** choose ** *****.

ISC **** ******** ***** ****

**** ******* *** **** ********** * years ****** ** ***'* *******. ***** every **-****** ***** *** ******** ** COVID-19, *** **** *** ************ ***** handled, **** *** **** ***** *********** from ***** **** ****** ****, **** ********* ****, **** ******* ****, *** **** ****** ****, **** ** *** ******* ****. When ** *** **** ** **** 2021, *** ****, *** *** ***** time ** **** **** ****, ******* to ******** **********.

******** ***** **** *** * ***** rescheduling *** *** ****'* ******* ** refunds *** ******* **** ** ********* fees, *.*.**** ********* **% ******* *** *** West ********** ******** *********** ********, ******* ***% ******* *** Exhibitors ******** *** **** ****. ******* ********** **** ******* *** frustrated ** *** ******** *******. ** contrast, **** ***, ****'* **** **** competitor, ******* **** ******* ** **********.

Tuchband ******

IPVM Image

****** *************** ****, ****** **** *********** **, previously ******* **** / **'* "*******, Vision, & **********" *****. ** ***** with ******** **** *** ****** **** he **** ****** *** *** **** in *** **** *** *****, ******** what ** ***** ** *** *** about *** ****, *** ***.

2021 ** ********** *******

******** ******** ** ***** ********** ******* from *** **** *** **** ****, saying:

** ********* ** *** ****, ********** numbers ***** ** *** **** *** whole *****. *** ***** ****** **** b2b ***** ****** **** **** ***** successfully ** **** *** **** ******* (in **** ***** **** ****** **** pre-covid) ************, ******** *****, ******, ***. from ***** **** ** *********** ** both ***** ** *** ******. **** without ******* ** ********** ******* *** the *** **** **** ****, *** volume ** ********* ********** ** *** upcoming *** **** **** **** ** a **** ********* *** *** ******** is ******* ***** *** ***** ** participating ** *** ******** *** **** 2022 ****.

**** ** ** *** *** *********** tactic. *** *****, **** ******* ***** ISC ****'* ********** *******, *** *********** *** **** **** **** ************ ****** **** "*** **** *********** a ****** **** ******* ** ********* to *** ***** ** *** ***** of **-**% ** **** ******* ******." And **** **** *** **** ******** and ********** ******* ****, ** ****** indications, *** *****, **** / ** cannot ****** ** **** **** ** the ********** *******.

**** *****, **** / ** ** tactically ******* **** ** **** ** exhibitors ******** ** *** *****, ********** numbers *** *********.

2022 **** ******

******** ******** ********* ******** ******** ***** ISC **** **** *** ** ******** data ******:

************ *** *** **** **** ******** started *** ***** ********** **** *** have **** ********. ***********, ********** **** also **** ********* **** *** ****** positive ********* ** ***** *** ****** research ****** ***** ******** *********/******** ********* when ** ***** ** ***** ****** attending *** ****, ******* ** ******** during *** ****, ***. **** ***** of ******** *** ** **** ******** by *** ****** ** ********** ******* the **** **** ****, ********* ***** booth *****, *** ********* ********** ****** advertising/sponsorship.

** *********** ******* **** **** ***** ******* ** ** ********* ****** **** last **** *** ************* ***** **** pre-COVID, ********* *** ******** ***** **** areas **** *** *** ******:

IPVM Image

Prices **, ********** ****

*** *********** ****** ** **** **** / ** ********* ** ******** ******* for *** ****, ******* *** ******* attendance ****** **** ***-***** ******. **** begs *** ******** ** *** **** the ***** ** *** **** ** changing *** ********** *** ***, ********* speaking, ****** **** *** ******* ****.

*** ****, ** ********** ********* *** sponsored *** **** *** ******* *** have ** ***** *** *** *********** future ** ****** ** *** ***** generated **** *** ****, ** ***** for **, *** ********, *** ** the ***** ******* ** **********.

Future *** ****

******** ***** ****** ************ *** *** show *** **** ***** ***** ** announced ** *** *** ** ******* future:

**** ** * **** **** ******** for *** *** **** **** *** myself ** **** **** *** ********* provide *********** ***** ** *** ******** for ***** ** ****. ** ** premature *** ** ** ** **** detail ** ******** ************ ** *** working ** *** **** *** ******, but ** **** ** ************* **** on **** ***** ** *** *** so ******* ******.

Power **** **********

*********'* ******** ********** *** ******* ** ISC ****. ***** *** ******** ** exhibitors *** ** ***** ******** **** close ** *** ***** ** *** West (**** ** **** **** ********* be ************* ******* **********). *** **** companies **** **** ** **** **** many ****** ** ****, ** ******, there ** ** ********* *********** (** exception ** ********* **** **** ***** own ******, ****** **** ** ******* to **** *** ********* *** ***** to ***** *** ***** ******** ** customers).

**** **** ** *********** ** *** is (*) *** **** **** / RX ****** *** ******** ***** ********* over ********** *** (*) *** **** (or ***) *** *** **** ****** to *** ***-******** *******?

Comments (13)

* **** ** ******* *** ***** on *** **-****** ***** *** ****. It ** * ****** *** *** worth *** ***** ****** ****** ****** down. *'** **** ******* ***** *** did *** ***** ** *** * especially ***'* **** ** ****** ** to ***** ****** **.

Agree: 2
Disagree
Informative
Unhelpful
Funny

****'* * *** *****. **** ****** in *** ** *** *** ********* about ***** **** ***** (** **** point **** ******* *** ********, ***.) but *** *********** *** ** **** about *** ********** ** ******* **** for * **** ***/** ******* ****** members ****. **'* ********* **** **** and ***** *** ***** * ********* consideration (****** * *******, ** **** last ****, *********** **** ** **** driven ** ** ** *****).

Agree: 2
Disagree
Informative
Unhelpful
Funny

****'* ***** * ** **. *'* in ** **'* *** *******, *******, and **** ** ************* ** * am *** ***** ********* ***** ***** or ***** ************ **** *****. *** I ***** ****** *** ** *** sick ** **** **** ** ** someone ****, ** ****** ******* ** high ***** ****** * ** ***** to **** **** **** ******* **** deciding **** *****, ********, ***. * will ******. ** ******* **** ** exhibiting ** *** **** *** * am ******** ** *********.

Agree: 2
Disagree
Informative: 2
Unhelpful
Funny

* ******** **** ** **** ***** for *** *** ******** **** **** role ** **** ****. *********, ** just ******* ** *** ********** *** establishes ** **** ******* ** *************. I ***** **** ** *** ****** really ***** ** **** ************* ** a **** ****** ******.

Agree: 6
Disagree
Informative
Unhelpful
Funny

** *** **** *** *** ********. He *** * ******* ****** ** position ******* ** *** *** *** and ******** ******* **** **** ******** previously. ** ******, ******* ** **** that ** ******* ***** ** *** material ******, ******* ** ** ****.

Agree: 3
Disagree
Informative
Unhelpful
Funny

**** **** **** ****.

Agree: 1
Disagree
Informative: 2
Unhelpful
Funny

**** *** ********** ******* *********** ** the ********* * **** **** ****, long ****, **** ** * *** move.

**** ******* ** * **** **** with *** ******* ** "*****, ******* arrogant **** *** **** **** *** to **** *** *** $$, ****** than ******** **** **** & ****** to ***** *** **** *** ********* benefit, *** **** ***** **** *******."

Agree: 2
Disagree
Informative
Unhelpful
Funny: 1

**** ******* **** *** *** ***** checking *** ****** *** ****** ***********. The ****** ****** **** **** ** mandates **** ****, *** ****** **** country ***** ******. **** **** **** their ********* ** "**********" **!

Agree: 3
Disagree
Informative: 1
Unhelpful
Funny

#*, * **** **** ****** **** ****** *** ****** ***********, ******* ***** *** ******:

***** ***********, ********* *********, ********** *** ISC *****, *** ******** ** ****** with *** *** **** ****** *** safety ************, *********, *** *** ******* to, ******* ** ******** **** ******** at *** ***** *** ********* ****** proof ** **** *********** ******* *****-** or * ******** *****-** **** ** a ********* ** *****

**** ** **** *********? ** **** not ******* ************, *** *** ********* to **** ***** **?

Agree
Disagree
Informative
Unhelpful
Funny

**'* **** **** **** *****:

************ ** **** ***********/******** ****

***** ****** **********

**** *********

Agree: 1
Disagree
Informative
Unhelpful
Funny

** **** *** * *** ******** ISC **** ****, **** ******* ******* to **** *****'* ****:

IPVM Image

**** ********* **** ****** ********** **** last **** *** ***** ************* **** than ***-********.

*** **** ****** * ***** ******* saying "******** ** **** ****’* *****" **** "pacing **** **% ***** ** ******** registrations". *** **** ********** ** **** that:

************ **** ******** ****** * *** weeks **** *** *** ******** ** our ********* ******* *** **** ******* up **** **** *** ****. ***** registration *** ******, ** *** ****** a ******** ************ ** ************ ****** and ****** **** **% ****** ** continue ** ****** ** *** ***** ahead. ** **** ******** ** **** positive ******** **** ******* ***** ********** on ***** *** ******* ** ******* appointments/meetings ***************** ******* *** ***********.

Agree
Disagree
Informative
Unhelpful
Funny

* ******* *** **** ** *** same **** ** "***** ******* **** Basketball". *** * ****** *** **** to ** ** *****. * ** forecasting * *** ** "********* ********" being **** ** ****** ***** ** night *** **** ******* ****** *** day. ***** *****, **** ** *** back ** *** ******** ** ******** partnerships!

Agree: 2
Disagree
Informative: 2
Unhelpful
Funny: 2

******: *** *** **** ********** **** "******** ************* ****** **** **% ***** of **** ****". *** **** ***** won't *** **** **** ****'* ************* were (**** **** ****** ********* ***). This ** * **** **** **** they *** ** **% **** **** year ****** ****** ***** *** ***** pre-COVID ******.

Agree
Disagree
Informative: 1
Unhelpful
Funny
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports